Abstract
Cytokine release syndrome (CRS) is a major obstacle to the widespread clinical application of chimeric antigen receptor (CAR)T cell therapies. CRS can also be induced by infections (such as SARS-CoV-2), drugs (such as therapeutic antibodies), and someautoimmune diseases. Myeloid-derived macrophages play key roles in the pathogenesis of CRS, and participate in the productionand release of the core CRS cytokines, including interleukin (IL)-1, IL-6, and interferon-γ. In this review, we summarize the roles ofmacrophages in CRS and discuss new developments in macrophage activation and the related mechanisms of cytokine regulationin CRS.

This publication has 91 references indexed in Scilit: